Last reviewed · How we verify
NCT04551118
Efficacy of Transcranial Electrical Stimulation (tES) on Emotion Processing
NA trial testing Transcranial alternating current stimulation (tACS) -active in Healthy in 102 participants. Completed in 1 September 2020.
20 August 2020
Quick facts
| Lead sponsor | Tianjin Anding Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 102 |
| Start date | 1 July 2019 |
| Primary completion | 20 August 2020 |
| Estimated completion | 1 September 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Transcranial alternating current stimulation (tACS) -active
- Transcranial direct current stimulation (tDCS)-active
- Transcranial electrical stimulation (TES)-sham
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Tianjin Anding Hospital
Who can join
Adults 18 to 35, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the efficacy of transcranial Electrical Stimulation (tES) on emotion processing of healthy participants. Meanwhile, the investigators evaluate the effect of tES on electroencephalography (EEG) of both resting and task-related signal. The hypothesis of this study is that tES can improve the cognitive function of emotion by modulating brain activity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Transcranial alternating current stimulation ameliorates emotional attention through neural oscillations modulation.
Liu S, He Y, Guo D, Liu X, et al · · 2023 · cited 14× · PMID 37969947 · DOI 10.1007/s11571-022-09880-5
Verify or expand the search:
- PubMed search for NCT04551118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Tianjin Anding Hospital trials
Trials by the same sponsor.
- NCT07393464 — PQQ for Cognitive and Negative Symptoms · NA · not yet recruiting
- NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
- NCT06812923 — TACS on High-inflammatory and Refractory Depression · NA · recruiting
- NCT07162467 — Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia. · enrolling by invitation
- NCT07359209 — Berberine Improving Cognitive Impairments in Schizophrenia · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04551118 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Anding Hospital
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04551118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing